Pioneers of RNA Therapeutics 

We develop targeted RNA therapies designed specifically to address rare monogenic genetic disorders. We are commited to improving patient outcomes and providing hope when options are limited.

Targeted Delivery

We employ novel lipid nanoparticle (LNP) encapsulation to protect and deliver RNA payloads to specific targets.

Scientific Excellence

We are research driven supported by world-leading scientific experts to ensure rigorous, novel and advanced therapeutics are developed. 

Patient Centric Approach

We are committed to providing hope and options for patients and their families for rare genetic disorders with high unmet medical need.

I hereby agree that this data will be stored and processed for the purpose of establishing contact. I am aware that I can revoke my consent at any time.*

*Please fill in all the required fields.
Message was successfully sent

Get in touch

Telephone: +447497313271

E-mail: anthony@morphian-therapeutics.com

Address: 71-75 Shelton Street, London, UK

©Copyright. All rights reserved.

Information icon

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.